ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.9796
-0.2804 (-22.25%)
At close: Oct 13, 2026, 4:00 PM EDT
1.140
+0.160 (16.37%)
After-hours: Oct 13, 2026, 7:59 PM EDT
ALX Oncology Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
135.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Precision BioSciences | 45.06M |
| Cue Biopharma | 37.66M |
| Adagene | 9.29M |
| Oramed Pharmaceuticals | 2.00M |
| Compass Therapeutics | 850.00K |
ALXO News
- 15 days ago - ALX Oncology announces publication of data from ASPEN-06 Phase 2 trial - TheFly
- 15 days ago - ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer - GlobeNewsWire
- 4 weeks ago - ALX Oncology Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - ALX Oncology Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - ALX Oncology Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 5 weeks ago - ALX Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 2 months ago - ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - ALX Oncology Holdings Earnings release: Q2 2026 - Filings